PUBLICATION REGISTRY

Go to research.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för zoledronic acid. Visa hela publikationsregistret

A publication hit is not a conclusion. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publications in the selection

20 hits

Bibliografisk träff 2021-09-28

The Interaction of Acute-Phase Reaction and Efficacy for Osteoporosis After Zoledronic Acid: HORIZON Pivotal Fracture Trial.

Black DM, Reid IR, Napoli N, Ewing SK, Shiraki M, Nakamura T, Takeuchi Y, Schafer AL, Kim TY, Cauley JA.

J Bone Miner Res · research support, non-u.s. gov't; research-article; randomized controlled trial; journal article · DOI 10.1002/jbmr.4434

Bibliografisk träff 2021-09-24

Effect of Primary Stabilisation on Osseointegration of Implants With Local and Systemic Zoledronic Acid Application.

Sokmen N, Dundar S, Bozoglan A, Yildirim TT, Sokmen K, Sayeste E, Isayev A, Kirtay M.

J Craniofac Surg · journal article · DOI 10.1097/scs.0000000000008236

Bibliografisk träff 2021-08-27

Postoperative zoledronic acid for osteoporosis in primary hyperparathyroidism: a randomized placebo-controlled study.

Ryhänen EM, Koski AM, Löyttyniemi E, Välimäki MJ, Kiviniemi U, Schalin-Jäntti C.

Eur J Endocrinol · randomized controlled trial; journal article · DOI 10.1530/eje-21-0322

Bibliografisk träff 2021-08-27

Retrospective Study of the Effects of Zoledronic Acid on Muscle Mass in Osteoporosis Patients.

Huang CF, Shiao MS, Mao TY.

Drug Des Devel Ther · research-article; journal article · DOI 10.2147/dddt.s328858

Bibliografisk träff 2021-08-19

Zoledronic acid-induced orbital inflammation.

Khalid MF, Micieli J.

BMJ Case Rep · journal article; case reports; case-report · DOI 10.1136/bcr-2021-245359

Bibliografisk träff 2021-08-15

Safety and Efficacy of Zoledronic Acid Treatment with and without Acetaminophen and Eldecalcitol for Osteoporosis.

Mochizuki T, Yano K, Ikari K, Okazaki K.

Intern Med · research-article; randomized controlled trial; journal article · DOI 10.2169/internalmedicine.6607-20

Bibliografisk träff 2021-08-10

Combination of Melatonin and Zoledronic Acid Suppressed the Giant Cell Tumor of Bone <i>in vitro</i> and <i>in vivo</i>.

Wang X, Su P, Kang Y, Xu C, Qiu J, Wu J, Sheng P, Huang D, Zhang Z.

Front Cell Dev Biol · research-article; journal article · DOI 10.3389/fcell.2021.690502

Bibliografisk träff 2021-08-02

Zoledronic acid and bone health in older adults with cognitive impairment.

Churilla BM, Perera S, Greenspan SL, Resnick NM, Kotlarczyk MP.

Osteoporos Int · research-article; randomized controlled trial; journal article · DOI 10.1007/s00198-021-06063-6

Bibliografisk träff 2021-07-30

Medication-Related Osteonecrosis of the Jaws Initiated by Zoledronic Acid and Potential Pathophysiology.

Alsalih A, Dam A, Lindberg P, Truedsson A.

Dent J (Basel) · review-article; review; journal article · DOI 10.3390/dj9080085

Bibliografisk träff 2021-06-03

Effects of ranibizumab and zoledronic acid on endometriosis in a rat model.

Ureyen Ozdemir E, Adali E, Islimye Taskin M, Yavasoglu A, Aktug H, Oltulu F, Inceboz U.

Arch Gynecol Obstet · research support, non-u.s. gov't; journal article · DOI 10.1007/s00404-021-06104-9

Bibliografisk träff 2021-06-01

Voltametric Determination of Zoledronic Acid in a Pharmaceutical Formulation

Amro A, Ratrout S, Asfour F.

Turk J Pharm Sci · research-article; journal article · DOI 10.4274/tjps.galenos.2020.97455

Bibliografisk träff 2021-05-12

Titanium implant alters the effect of zoledronic acid on the behaviour of endothelial cells.

Yu Y, Liang C, Xu R, Wang T, Deng F, Yu X.

Oral Dis · journal article · DOI 10.1111/odi.13890

Bibliografisk träff 2021-05-11

Development of Zoledronic Acid Containing Biomaterials for Enhanced Guided Bone Regeneration.

Küçüktürkmen B, Öz UC, Toptaş M, Devrim B, Saka OM, Bilgili H, Deveci MS, Ünsal E, Bozkır A.

J Pharm Sci · research support, non-u.s. gov't; journal article · DOI 10.1016/j.xphs.2021.05.002

Bibliografisk träff 2009-10-01

Is zoledronic acid an anticancer drug?

Doggrell SA.

Expert Opin Pharmacother · comment; journal article · DOI 10.1517/14656560903173245

Bibliografisk träff 2008-01-01

Once-yearly zoledronic acid in the prevention of osteoporotic bone fractures in postmenopausal women.

Lambrinoudaki I, Vlachou S, Galapi F, Papadimitriou D, Papadias K.

Clin Interv Aging · review-article; review; journal article · DOI 10.2147/cia.s2046

Bibliografisk träff 2007-01-01

Zoledronic acid - a multiplicity of anti-cancer action.

Yuasa T, Kimura S, Ashihara E, Habuchi T, Maekawa T.

Curr Med Chem · research support, non-u.s. gov't; review; journal article · DOI 10.2174/092986707781389600

Bibliografisk träff 2006-01-01

Rationale for zoledronic acid therapy in men with hormone-sensitive prostate cancer with or without bone metastasis.

Saad F, McKiernan J, Eastham J.

Urol Oncol · review; journal article · DOI 10.1016/j.urolonc.2005.06.020

Bibliografisk träff 2004-12-01

Zoledronic acid up-regulates bone sialoprotein expression in osteoblastic cells through Rho GTPase inhibition.

Chaplet M, Detry C, Deroanne C, Fisher LW, Castronovo V, Bellahcéne A.

Biochem J · research support, non-u.s. gov't; research-article; journal article · DOI 10.1042/bj20040380

Bibliografisk träff 2004-01-01

Zoledronic acid: a review of its use in patients with advanced cancer.

Perry CM, Figgitt DP.

Drugs · review; journal article · DOI 10.2165/00003495-200464110-00004

Bibliografisk träff 2002-09-01

Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid.

Wood J, Bonjean K, Ruetz S, Bellahcène A, Devy L, Foidart JM, Castronovo V, Green JR.

J Pharmacol Exp Ther · research support, non-u.s. gov't; journal article · DOI 10.1124/jpet.102.035295